Nifty

:

22402.40

Sensex

:

73852.94

34.40 (0.15%)
114.49 (0.16%)

Login

Nifty
Sensex

:
:

22402.40
73852.94

34.40 (0.15%)
114.49 (0.16%)

Tatva Chintan Pharma Chem Ltd.

Chemicals

Rating :

36/99

BSE: 543321 | NSE: TATVA

Watchlist

NSE BSE

1252.85

24-Apr-2024

Open
High
Low
Previous Close

1245.00
1270.10
1232.05
1238.45

Volume
Traded Value (lacs)
52 Week High
52 Week Low

10456
131.21
1887.95
1061.35

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,925.64
77.62
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,842.90
0.16%
4.00

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

17.50
15.48
12.14

EBITDA CAGR (%)

10 Years
5 Years
3 Years

17.71
12.24
-1.84

PAT CAGR (%)

10 Years
5 Years
3 Years

22.71
17.24
-4.52

P:E (Median)

8 Years
5 Years
3 Years

-
-
82.62

P:BV (Average)

8 Years
5 Years
3 Years

-
-
8.87

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
56.84

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 86.07 113.54 -24.19% 92.57 84.04 10.15% 106.10 86.06 23.29% 119.41 101.88 17.21%
Expenses 73.76 96.69 -23.71% 71.83 75.10 -4.35% 86.49 72.57 19.18% 104.00 79.78 30.36%
EBITDA 12.31 16.85 -26.94% 20.74 8.93 132.25% 19.61 13.50 45.26% 15.40 22.10 -30.32%
EBIDTM 14.31% 14.84% 22.41% 10.63% 18.48% 15.68% 12.90% 21.69%
Other Income 1.21 1.07 13.08% 0.76 1.95 -61.03% 1.02 1.88 -45.74% 0.78 1.19 -34.45%
Interest 0.38 2.38 -84.03% 3.01 1.76 71.02% 2.90 1.06 173.58% 3.18 1.18 169.49%
Depreciation 6.58 2.38 176.47% 6.78 2.31 193.51% 6.01 2.33 157.94% 2.53 2.15 17.67%
PBT 6.56 13.15 -50.11% 11.71 6.81 71.95% 11.72 11.98 -2.17% 6.89 19.96 -65.48%
Tax 1.91 2.60 -26.54% 3.50 1.56 124.36% 3.47 3.48 -0.29% -9.26 1.08 -
PAT 4.65 10.56 -55.97% 8.20 5.26 55.89% 8.25 8.50 -2.94% 16.15 18.89 -14.51%
PATM 5.40% 9.30% 8.86% 6.25% 7.77% 9.88% 13.53% 18.54%
EPS 1.99 4.51 -55.88% 3.51 2.25 56.00% 3.52 3.63 -3.03% 6.90 8.07 -14.50%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 84.21 120.61 -30.18% 96.67 90.09 7.30% 114.36 88.40 29.37% 124.51 98.53 26.37%
Expenses 73.21 102.69 -28.71% 76.42 78.91 -3.16% 93.02 73.19 27.09% 108.24 76.54 41.42%
EBITDA 10.99 17.91 -38.64% 20.25 11.18 81.13% 21.34 15.22 40.21% 16.27 21.99 -26.01%
EBIDTM 13.06% 14.85% 20.95% 12.41% 18.66% 17.21% 13.07% 22.32%
Other Income 1.21 1.08 12.04% 0.76 1.95 -61.03% 1.02 1.88 -45.74% 0.85 0.31 174.19%
Interest 0.38 2.38 -84.03% 3.01 1.76 71.02% 2.93 1.06 176.42% 3.20 1.18 171.19%
Depreciation 6.58 2.38 176.47% 6.78 2.31 193.51% 6.01 2.33 157.94% 2.53 2.15 17.67%
PBT 5.24 14.22 -63.15% 11.21 9.06 23.73% 13.42 13.69 -1.97% 7.80 18.98 -58.90%
Tax 1.79 2.60 -31.15% 3.43 1.95 75.90% 3.92 3.90 0.51% -9.15 1.47 -
PAT 3.45 11.62 -70.31% 7.78 7.11 9.42% 9.50 9.80 -3.06% 16.95 17.51 -3.20%
PATM 4.10% 9.64% 8.05% 7.89% 8.31% 11.08% 13.62% 17.77%
EPS 1.48 5.24 -71.76% 3.33 3.21 3.74% 4.29 4.42 -2.94% 7.65 7.90 -3.16%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 404.15 403.04 427.81 291.19 253.84 202.90 89.93 101.57 80.35 52.80 48.00 Net Sales Growth 4.83% -5.79% 46.92% 14.71% 25.11% 125.62% -11.46% 26.41% 52.18% 10.0% Cost Of Goods Sold 200.81 222.33 196.45 148.33 130.13 115.18 47.95 63.68 49.91 0.00 0.00 Gross Profit 203.34 180.72 231.36 142.86 123.71 87.72 41.98 37.89 30.43 52.80 48.00 GP Margin 50.31% 44.84% 54.08% 49.06% 48.74% 43.23% 46.68% 37.30% 37.87% 100% 100% Total Expenditure 336.08 348.23 321.81 225.79 201.14 169.71 75.09 90.30 69.62 52.89 48.04 Power & Fuel Cost - 23.61 22.62 9.92 8.96 6.25 1.53 3.25 2.91 0.00 0.00 % Of Sales - 5.86% 5.29% 3.41% 3.53% 3.08% 1.70% 3.20% 3.62% 0% 0% Employee Cost - 38.60 30.82 23.80 20.53 16.31 6.97 8.13 4.39 0.00 0.00 % Of Sales - 9.58% 7.20% 8.17% 8.09% 8.04% 7.75% 8.00% 5.46% 0% 0% Manufacturing Exp. - 30.72 42.30 26.38 23.99 13.88 3.18 6.37 4.28 0.00 0.00 % Of Sales - 7.62% 9.89% 9.06% 9.45% 6.84% 3.54% 6.27% 5.33% 0% 0% General & Admin Exp. - 12.94 9.10 6.88 5.96 7.57 3.53 1.71 1.40 52.80 48.00 % Of Sales - 3.21% 2.13% 2.36% 2.35% 3.73% 3.93% 1.68% 1.74% 100% 100% Selling & Distn. Exp. - 15.61 19.52 9.72 9.66 8.56 0.00 1.48 1.61 0.00 0.00 % Of Sales - 3.87% 4.56% 3.34% 3.81% 4.22% 0% 1.46% 2.00% 0% 0% Miscellaneous Exp. - 4.42 1.01 0.76 1.91 1.96 11.93 5.68 5.12 0.09 0.00 % Of Sales - 1.10% 0.24% 0.26% 0.75% 0.97% 13.27% 5.59% 6.37% 0.17% 0.08% EBITDA 68.06 54.81 106.00 65.40 52.70 33.19 14.84 11.27 10.73 -0.09 -0.04 EBITDA Margin 16.84% 13.60% 24.78% 22.46% 20.76% 16.36% 16.50% 11.10% 13.35% -0.17% -0.08% Other Income 3.77 5.68 10.63 5.10 0.56 0.44 0.78 1.43 0.13 5.47 5.26 Interest 9.47 8.52 5.19 4.41 4.25 3.94 1.79 2.47 2.13 1.92 1.89 Depreciation 21.90 9.55 8.18 6.73 4.79 4.01 2.19 1.86 0.83 0.75 0.65 PBT 36.88 42.42 103.27 59.35 44.22 25.68 11.63 8.37 7.89 2.71 2.69 Tax -0.38 -1.63 7.28 7.99 9.25 6.24 4.21 2.72 2.67 0.89 0.94 Tax Rate -1.03% -4.20% 7.05% 13.46% 20.92% 23.61% 36.20% 32.50% 33.84% 32.84% 34.94% PAT 37.25 40.47 95.99 51.36 34.96 20.19 7.43 5.65 5.23 1.82 1.75 PAT before Minority Interest 37.25 40.47 95.99 51.36 34.96 20.19 7.43 5.65 5.23 1.82 1.75 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.22% 10.04% 22.44% 17.64% 13.77% 9.95% 8.26% 5.56% 6.51% 3.45% 3.65% PAT Growth -13.79% -57.84% 86.90% 46.91% 73.16% 171.74% 31.50% 8.03% 187.36% 4.00% EPS 15.92 17.29 41.02 21.95 14.94 8.63 3.18 2.41 2.24 0.78 0.75

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 419.75 423.61 433.65 300.36 263.24 206.31 Net Sales Growth 5.56% -2.32% 44.38% 14.10% 27.59% Cost Of Goods Sold 207.71 226.10 194.64 152.00 132.77 114.24 Gross Profit 212.04 197.51 239.01 148.35 130.47 92.07 GP Margin 50.52% 46.63% 55.12% 49.39% 49.56% 44.63% Total Expenditure 350.89 362.83 325.13 233.68 207.96 172.19 Power & Fuel Cost - 23.61 22.62 9.92 8.96 6.25 % Of Sales - 5.57% 5.22% 3.30% 3.40% 3.03% Employee Cost - 38.60 30.82 23.80 20.53 16.31 % Of Sales - 9.11% 7.11% 7.92% 7.80% 7.91% Manufacturing Exp. - 30.72 42.30 26.38 24.00 13.88 % Of Sales - 7.25% 9.75% 8.78% 9.12% 6.73% General & Admin Exp. - 13.90 9.76 7.21 6.58 8.06 % Of Sales - 3.28% 2.25% 2.40% 2.50% 3.91% Selling & Distn. Exp. - 20.95 23.87 13.56 11.88 11.13 % Of Sales - 4.95% 5.50% 4.51% 4.51% 5.39% Miscellaneous Exp. - 8.94 1.13 0.80 3.24 2.32 % Of Sales - 2.11% 0.26% 0.27% 1.23% 1.12% EBITDA 68.85 60.78 108.52 66.68 55.28 34.12 EBITDA Margin 16.40% 14.35% 25.02% 22.20% 21.00% 16.54% Other Income 3.84 5.74 9.02 5.20 1.38 0.49 Interest 9.52 8.60 5.23 4.45 4.27 3.95 Depreciation 21.90 9.55 8.18 6.73 4.79 4.02 PBT 37.67 48.37 104.12 60.70 47.60 26.64 Tax -0.01 -0.71 8.25 8.43 9.81 6.85 Tax Rate -0.03% -1.59% 7.92% 13.89% 20.61% 25.01% PAT 37.68 45.49 95.87 52.26 37.79 20.54 PAT before Minority Interest 37.68 45.49 95.87 52.26 37.79 20.54 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.98% 10.74% 22.11% 17.40% 14.36% 9.96% PAT Growth -18.16% -52.55% 83.45% 38.29% 83.98% EPS 16.10 19.44 40.97 22.33 16.15 8.78

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 504.78 468.88 161.94 114.45 79.64 15.93 10.36 8.27 6.13 4.80 Share Capital 22.16 22.16 20.09 8.04 8.04 4.36 4.00 3.73 3.41 3.23 Total Reserves 482.62 446.71 141.85 106.41 71.60 11.57 6.36 4.54 2.72 1.57 Non-Current Liabilities -6.98 5.06 30.82 43.59 35.16 8.29 7.49 7.89 4.45 12.74 Secured Loans 4.23 13.11 26.76 38.71 31.52 1.71 1.76 2.56 1.35 10.77 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 5.29 4.58 4.37 2.35 1.37 Long Term Provisions 1.15 0.65 0.55 0.40 0.29 0.00 0.00 0.00 0.00 0.00 Current Liabilities 244.70 193.55 127.08 87.26 72.57 28.54 20.79 17.65 12.20 6.16 Trade Payables 31.61 44.06 47.04 31.23 22.05 14.28 6.95 7.03 4.37 5.70 Other Current Liabilities 56.55 56.66 20.39 15.49 10.57 0.46 0.54 0.44 0.52 0.27 Short Term Borrowings 156.21 92.47 49.29 40.49 39.91 13.80 13.30 10.16 7.30 0.00 Short Term Provisions 0.33 0.37 10.35 0.06 0.04 0.00 0.00 0.01 0.01 0.19 Total Liabilities 742.50 667.49 319.84 245.30 187.37 52.76 38.64 33.81 22.78 23.70 Net Block 196.22 159.61 120.45 111.18 66.71 12.20 11.02 10.91 9.00 8.82 Gross Block 231.75 186.14 138.88 122.48 73.45 15.71 13.97 13.15 10.63 9.99 Accumulated Depreciation 35.53 26.53 18.43 11.30 6.74 3.51 2.95 2.24 1.63 1.17 Non Current Assets 431.03 214.37 131.22 116.90 73.78 15.09 13.80 13.36 9.03 8.82 Capital Work in Progress 230.74 51.49 9.81 4.89 6.04 0.20 0.00 0.01 0.00 0.00 Non Current Investment 0.67 0.67 0.67 0.67 0.67 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 2.85 2.09 0.30 0.17 0.38 2.68 2.77 2.45 0.03 0.00 Other Non Current Assets 0.55 0.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 311.47 453.12 188.61 128.40 113.58 37.44 24.69 20.39 13.73 14.86 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 151.45 160.69 68.36 58.72 31.06 10.86 7.40 6.77 6.53 5.88 Sundry Debtors 90.04 61.60 90.34 50.97 44.65 18.89 11.99 8.64 4.42 5.50 Cash & Bank 38.58 174.74 3.59 9.82 15.66 2.58 1.54 1.23 0.62 1.25 Other Current Assets 31.39 5.37 6.41 2.85 22.20 5.12 3.76 3.75 2.16 2.22 Short Term Loans & Adv. 26.30 50.72 19.92 6.04 18.55 5.12 3.76 3.75 2.16 2.22 Net Current Assets 66.77 259.57 61.54 41.14 41.01 8.91 3.90 2.74 1.53 8.70 Total Assets 742.50 667.49 319.83 245.30 187.36 52.75 38.65 33.81 22.78 23.70

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 514.79 473.09 165.96 117.69 79.70 Share Capital 22.16 22.16 20.09 8.04 8.04 Total Reserves 492.63 450.92 145.88 109.66 71.67 Non-Current Liabilities -6.98 5.06 30.82 43.59 35.16 Secured Loans 4.23 13.11 26.76 38.71 31.52 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.15 0.65 0.55 0.40 0.29 Current Liabilities 236.13 171.20 128.41 87.65 72.65 Trade Payables 32.19 44.51 47.48 31.61 22.13 Other Current Liabilities 47.19 33.01 20.74 15.49 10.57 Short Term Borrowings 156.21 92.47 49.29 40.49 39.91 Short Term Provisions 0.55 1.20 10.89 0.06 0.04 Total Liabilities 743.94 649.35 325.19 248.93 187.51 Net Block 196.25 159.61 120.45 111.18 66.71 Gross Block 231.78 186.14 138.88 122.48 73.46 Accumulated Depreciation 35.53 26.53 18.44 11.30 6.74 Non Current Assets 430.39 213.71 130.55 116.24 73.12 Capital Work in Progress 230.74 51.49 9.81 4.89 6.04 Non Current Investment 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 2.85 2.09 0.30 0.17 0.38 Other Non Current Assets 0.55 0.51 0.00 0.00 0.00 Current Assets 313.56 435.64 194.64 132.70 114.38 Current Investments 0.00 0.00 0.00 0.00 0.00 Inventories 162.50 169.96 72.02 63.55 35.59 Sundry Debtors 84.40 56.60 90.74 49.57 41.26 Cash & Bank 44.76 176.99 5.34 10.83 15.74 Other Current Assets 21.89 5.38 6.38 2.85 21.79 Short Term Loans & Adv. 16.76 26.72 20.16 5.89 18.14 Net Current Assets 77.42 264.44 66.23 45.05 41.73 Total Assets 743.95 649.35 325.19 248.94 187.50

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 23.73 19.76 18.91 24.64 7.87 3.29 2.50 0.00 0.00 0.00 PBT 38.83 103.27 59.35 44.22 26.43 7.89 2.71 0.00 0.00 0.00 Adjustment 15.82 9.64 6.92 8.20 7.49 1.89 1.66 0.00 0.00 0.00 Changes in Working Capital -23.18 -75.18 -37.55 -20.40 -20.31 -3.97 -1.17 0.00 0.00 0.00 Cash after chg. in Working capital 31.47 37.73 28.73 32.02 13.61 5.82 3.20 0.00 0.00 0.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -7.74 -17.97 -9.82 -7.39 -5.74 -2.53 -0.70 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -101.12 -196.69 -20.61 -40.18 -16.77 -2.58 -1.08 0.00 0.00 0.00 Net Fixed Assets -224.86 -88.94 -21.32 -47.88 -63.58 -1.94 -0.81 -2.53 -0.64 -4.35 Net Investments 0.00 0.00 0.00 0.00 -0.67 0.00 0.00 0.00 0.00 0.00 Others 123.74 -107.75 0.71 7.70 47.48 -0.64 -0.27 2.53 0.64 4.35 Cash from Financing Activity 37.81 235.01 -4.72 9.70 17.40 0.33 -1.10 0.00 0.00 0.00 Net Cash Inflow / Outflow -39.58 58.08 -6.42 -5.85 8.50 1.04 0.31 0.00 0.00 0.00 Opening Cash & Equivalents 60.77 2.73 9.15 15.66 7.17 1.54 1.23 0.00 0.00 0.00 Closing Cash & Equivalent 21.19 60.77 2.73 9.82 15.66 2.58 1.54 0.00 0.00 0.00

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity 27.78 20.23 19.69 25.31 7.36 PBT 44.78 104.12 60.70 47.60 27.39 Adjustment 20.71 11.63 6.85 8.56 7.57 Changes in Working Capital -28.41 -77.11 -38.04 -22.64 -21.66 Cash after chg. in Working capital 37.07 38.64 29.50 33.51 13.31 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -9.29 -18.41 -9.81 -8.20 -5.95 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -101.14 -196.69 -20.66 -40.18 -16.77 Net Fixed Assets -224.86 -88.94 -21.32 -47.88 Net Investments 0.00 0.00 0.00 0.00 Others 123.72 -107.75 0.66 7.70 Cash from Financing Activity 37.80 235.01 -4.71 9.95 17.40 Net Cash Inflow / Outflow -35.56 58.55 -5.67 -4.92 7.99 Opening Cash & Equivalents 63.02 4.48 10.16 15.74 7.76 Closing Cash & Equivalent 27.37 63.02 4.48 10.83 15.74

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 227.74 211.54 80.61 56.97 99.11 36.03 25.52 21.99 17.94 14.79 ROA 5.74% 19.44% 18.18% 16.16% 12.10% 11.44% 5.02% 6.20% 3.56% 4.44% ROE 8.31% 30.43% 37.16% 36.03% 28.76% 40.35% 19.75% 24.48% 15.20% 20.34% ROCE 7.49% 25.79% 27.88% 26.78% 22.19% 29.77% 16.80% 21.57% 13.98% 16.66% Fixed Asset Turnover 1.93 2.63 2.23 2.59 2.84 5.42 3.89 4.04 2.69 3.63 Receivable days 68.49 64.78 88.57 68.75 72.32 70.03 71.31 49.67 65.22 73.06 Inventory Days 140.96 97.66 79.65 64.54 49.92 41.43 48.99 50.55 81.51 61.13 Payable days 62.12 84.63 96.30 48.79 51.46 4651.92 3411.13 3207.32 3650.00 4956.31 Cash Conversion Cycle 147.33 77.81 71.91 84.50 70.78 -4540.46 -3290.84 -3107.10 -3503.26 -4822.11 Total Debt/Equity 0.34 0.26 0.56 0.79 0.97 1.32 1.92 2.08 1.80 2.54 Interest Cover 5.56 20.90 14.45 11.40 7.71 4.98 2.41 2.43 2.13 2.23

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 232.25 213.44 82.62 58.59 99.19 ROA 6.53% 19.68% 18.21% 17.32% 12.28% ROE 9.21% 30.01% 36.85% 38.29% 28.95% ROCE 8.35% 25.75% 28.04% 28.40% 22.78% Fixed Asset Turnover 2.03 2.67 2.30 2.69 2.88 Receivable days 60.72 61.98 85.26 62.97 64.50 Inventory Days 143.16 101.78 82.38 68.74 57.57 Payable days 61.91 86.25 94.96 48.09 50.05 Cash Conversion Cycle 141.97 77.51 72.67 83.61 72.03 Total Debt/Equity 0.33 0.25 0.54 0.77 0.97 Interest Cover 6.21 20.90 14.65 12.15 7.94

Top Investors:

nippon life india trustee ltd-a/c nippon india elss tax saver fund

sbi magnum midcap fund

goldman sachs funds - goldman sachs india equity portfolio

icici prudential smallcap fund

mirae asset aggressive hybrid fund

Annual Reports:

News Update:

Tatva Chintan Pharma - Quarterly Results
20th Jan 2024, 15:26 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback